Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bo Huang has a total of 62 co-authors. Here are the top co-authors by number of shared publications:

  • Lei Jin

    Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    9 shared publications
  • Lei Jin

    Reproductive Medicine Center, Tongji Hospital, Tongji Medicine College, Huazhong University of Science and Technology, Wuhan, 430030, China

    8 shared publications
  • Bingxin Ma

    Reproductive Medicine Center, Tongji Hospital, Tongji Medical college, Huazhong University of Science and Technology

    7 shared publications
  • Xinling Ren

    Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    6 shared publications
  • Keyi Si

    Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    5 shared publications
  • Li Wu

    Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

    5 shared publications

Latest Publications

  • Open Access

    The impact of diet on male semen quality and fertility: A comprehensive review

    by Bingxin Ma, Jingjing Zhu, Bo Huang

    Male factor infertility contributes to approximately 50% of all infertility cases, and global semen quality has declined substantially over recent decades, with modifiable lifestyle factors, particularly diet, implicated as key drivers. This comprehensive review synthesizes evidence from observational studies and randomized controlled trials examining associations between dietary components and male reproductive outcomes, with emphasis on underlying biological mechanisms. Despite growing interest in this field, well-designed randomized controlled trials examining clinically meaningful fertility outcomes remain scarce, and most available evidence derives from observational studies with inherent methodological limitations. Current evidence suggests that healthy dietary patterns, particularly the Mediterranean diet, are associated with superior semen parameters through mechanisms including reduced oxidative stress, improved hormonal profiles, and epigenetic modulation. Specific foods (nuts, fish, fruits, vegetables) and nutrients (omega-3 fatty acids, selenium, zinc, coenzyme Q10, antioxidants) demonstrate beneficial effects on sperm concentration, motility, morphology, and DNA integrity. However, while improvements in conventional semen parameters are well-documented, evidence for enhanced pregnancy and live birth rates remains limited, with meta-analyses showing inconsistent associations between dietary factors and assisted reproductive technology (ART) outcomes. Whether improvements in sperm parameters translate to clinically meaningful increases in live birth rates remains an open question requiring further investigation. Conversely, Western dietary patterns, ultra-processed foods, and specific dietary components (processed meats, trans fatty acids, phytoestrogens at high doses) are associated with poorer semen quality through pro-inflammatory pathways, endocrine disruption, and direct genotoxicity. Notably, pesticide residues in conventionally grown produce may attenuate the benefits of fruit and vegetable consumption via oxidative stress and androgen receptor antagonism. Weight management through dietary intervention significantly improves sperm parameters, with emerging evidence suggesting glucagon-like peptide-1 (GLP-1) receptor agonists may offer additional benefits for obese men. This review identifies critical knowledge gaps—including the paucity of trials with live birth as primary outcome, heterogeneity in study designs, and limited evidence for personalized nutrition approaches—and provides evidence-based dietary recommendations for men planning paternity.

  • Open Access

    Timelapse-based 3D reconstruction of blastocysts reveals 3D morphologies of human blastocysts

    by Bo Huang, Keyi Si, Yaxian Guo, Xuefeng Wang, Wenjing Zhou, Bingxin Ma, Xinling Ren, Li Wu, Jing Yue, Jinzhong Wang, et al.

    Assessing blastocysts from a three-dimensional (3D) perspective introduces a novel approach to clinical embryo evaluation. Currently, assisted reproduction laboratories lack clinically compatible methods to reconstruct 3D blastocyst structures without interfering with embryo culture. To address this, we developed an interference-free and non-invasive method that uses widely adopted time-lapse (TL) imaging systems to reconstruct 3D blastocyst structures directly from multi-focal images and quantitatively calculate various 3D morphological parameters, without requiring embryologist intervention. In this study, we reconstructed 3D structures for 2025 blastocysts using 22,275 TL images and analyzed the association between 20 3D morphological features and embryo transfer outcomes. Several parameters were significantly associated with clinical pregnancy and live birth (P < 0.05). This method is fully compatible with current clinical workflows, providing objective and comprehensive 3D data for blastocyst assessment. It holds strong potential for future implementation in standardized and automated embryo selection based on quantitative morphological criteria.


  • Open Access

    Predictive Ability of an Objective and Time-Saving Blastocyst Scoring Model on Live Birth

    by Bing-Xin Ma, Feng Zhou, Guang-Nian Zhao, Lei Jin, Bo Huang

    Objectives: With the development of artificial intelligence technology in medicine, an intelligent deep learning-based embryo scoring system (iDAScore) has been developed on full-time lapse sequences of embryos. It automatically ranks embryos according to the likelihood of achieving a fetal heartbeat with no manual input from embryologists. To ensure its performance, external validation studies should be performed at multiple clinics. Methods: A total of 6291 single vitrified–thawed blastocyst transfer cycles from 2018 to 2021 at the Reproductive Medicine Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology were retrospectively analyzed by the iDAScore model. Patients with two or more blastocysts transferred and blastocysts that were not cultured in a time-lapse incubator were excluded. Blastocysts were divided into four comparably sized groups by first sorting their iDAScore values in ascending order and then compared with the clinical, perinatal, and neonatal outcomes. Results: Our results showed that clinical pregnancy, miscarriage, and live birth significantly correlated with iDAScore (p < 0.001). For perinatal and neonatal outcomes, no significant difference was shown in four iDAScore groups, except sex ratio. Uni- and multivariable logistic regressions showed that iDAScore was significantly positively correlated with live birth rate (p < 0.05). Conclusions: In conclusion, the objective ranking can prioritize embryos reliably and rapidly for transfer, which could allow embryologists more time for processes requiring hands-on procedures.


  • Open Access

    Preimplantation development analysis of aneuploid embryos with different chromosomal abnormalities

    by Keyi Si, Bingxin Ma, Jian Bai, Li Wu, Hui He, Lei Jin, Bo Huang


  • The density of the inner cell mass is a new indicator of the quality of a human blastocyst: a valid supplement to the Gardner scoring system

    by Bo Huang, Zhou Li, Xinling Ren, Jian Bai, Jing Yue, Xiyuan Dong, Liu Yang, Bingxin Ma, Jinzhong Wang, Wenjing Zhou, et al.

    Can the density of the inner cell mass (ICM) be a new indicator of the quality of the human blastocyst? The densification index (DI) developed in this study can quantify ICM density and provide positive guidance for ploidy, pregnancy, and live birth. In evaluating the quality of ICM, reproductive care clinics still use size indicators without further evaluation. The main disadvantage of this current method is that the evaluation of blastocyst ICM is relatively rough and cannot meet the needs of clinical embryologists, especially when multiple blastocysts have the same ICM score, which makes them difficult to evaluate further. This observational study included data from 2272 blastocysts in 1991 frozen–thawed embryo transfer (FET) cycles between January 2018 to November 2021 and 1105 blastocysts in 430 preimplantation genetic testing cycles between January 2019 and February 2023. FET, ICSI, blastocyst culture, trophectoderm biopsy, time-lapse (TL) monitoring, and next-generation sequencing were performed. After preliminary sample size selection, the 11 focal plane images captured by the TL system were normalized and the spatial frequency was used to construct the DI of the ICM. This study successfully constructed a quantitative indicator DI that can reflect the degree of ICM density in terms of fusion and texture features. The higher the DI value, the better the density of the blastocyst ICM, and the higher the chances that the blastocyst was euploid (P < 0.001) and that pregnancy (P < 0.001) and live birth (P = 0.005) were reached. In blastocysts with ICM graded B and blastocysts graded 4BB, DI was also positively associated with ploidy, pregnancy, and live birth (P < 0.05). ROC analysis showed that combining the Gardner scoring system with DI can more effectively predict pregnancy and live births, when compared to using the Gardner scoring system alone. Accurate calculation of the DI value places high demands on image quality, requiring manual selection of the clearest focal plane and exposure control. Images with the ICM not completely within the field of view cannot be used. The association between the density of ICM and chromosomal mosaicism was not evaluated. The associations between the density of ICM and different assisted reproductive technologies and different culture conditions in embryo laboratories were also not evaluated. Prospective studies are needed to further investigate the impact of ICM density on clinical outcomes. ICM density assessment is a new direction in blastocyst assessment. This study explores new ways of assessing blastocyst ICM density and develops quantitative indicators and a corresponding qualitative evaluation scheme for ICM density. The DI of the blastocyst ICM developed in this study is easy to calculate and requires only TL equipment and image processing, providing positive guidance for clinical outcomes. The qualitative evaluation scheme of ICM density can assist embryologists without TL equipment to manually evaluate ICM density. ICM density is a simple indicator that can be used in practice and is a good complement to the blastocyst scoring systems currently used in most centers. This work was supported by the National Key Research & Development Program of China (2021YFC2700603). The authors report no financial or commercial conflicts of interest. N/A.


  • Open Access

    Multiple collapses of blastocysts after full blastocyst formation is an independent risk factor for aneuploidy — a study based on AI and manual validation

    by Lei Jin, Keyi Si, Zhou Li, Hui He, Li Wu, Bingxin Ma, Xinling Ren, Bo Huang

    Background: The occurrence of blastocyst collapse may become an indicator of preimplantation embryo quality assessment. It has been reported that collapsing blastocysts can lead to higher rates of aneuploidy and poorer clinical outcomes, but more large-scale studies are needed to explore this relationship. This study explored the characteristics of blastocyst collapse identified and quantified by artificial intelligence and explored the associations between blastocyst collapse and embryo ploidy, morphological quality, and clinical outcomes. Methods: This observational study included data from 3288 biopsied blastocysts in 1071 time-lapse preimplantation genetic testing cycles performed between January 2019 and February 2023 at a single academic fertility center. All transferred blastocysts are euploid blastocysts. The artificial intelligence recognized blastocyst collapse in time-lapse microscopy videos and then registered the collapsing times, and the start time, the recovery duration, the shrinkage percentage of each collapse. The effects of blastocyst collapse and embryo ploidy, pregnancy, live birth, miscarriage, and embryo quality were studied using available data from 1196 euploid embryos and 1300 aneuploid embryos. Results: 5.6% of blastocysts collapsed at least once only before the full blastocyst formation (tB), 19.4% collapsed at least once only after tB, and 3.1% collapsed both before and after tB. Multiple collapses of blastocysts after tB (times ≥ 2) are associated with higher aneuploid rates (54.6%, P > 0.05; 70.5%, P < 0.001; 72.5%, P = 0.004; and 71.4%, P = 0.049 in blastocysts collapsed 1, 2, 3 or ≥ 4 times), which remained significant after adjustment for confounders (OR = 2.597, 95% CI 1.464–4.607, P = 0.001). Analysis of the aneuploid embryos showed a higher ratio of collapses and multiple collapses after tB in monosomies and embryos with subchromosomal deletion of segmental nature (P < 0.001). Blastocyst collapse was associated with delayed embryonic development and declined blastocyst quality. There is no significant difference in pregnancy and live birth rates between collapsing and non-collapsing blastocysts. Conclusions: Blastocyst collapse is common during blastocyst development. This study underlined that multiple blastocyst collapses after tB may be an independent risk factor for aneuploidy which should be taken into account by clinicians and embryologists when selecting blastocysts for transfer.


  • Open Access

    Enhancing clinical utility: deep learning-based embryo scoring model for non-invasive aneuploidy prediction

    by Bing-Xin Ma, Guang-Nian Zhao, Zhi-Fei Yi, Yong-Le Yang, Lei Jin, Bo Huang

    Background: The best method for selecting embryos ploidy is preimplantation genetic testing for aneuploidies (PGT-A). However, it takes more labour, money, and experience. As such, more approachable, non- invasive techniques were still needed. Analyses driven by artificial intelligence have been presented recently to automate and objectify picture assessments. Methods: In present retrospective study, a total of 3448 biopsied blastocysts from 979 Time-lapse (TL)-PGT cycles were retrospectively analyzed. The “intelligent data analysis (iDA) Score” as a deep learning algorithm was used in TL incubators and assigned each blastocyst with a score between 1.0 and 9.9. Results: Significant differences were observed in iDAScore among blastocysts with different ploidy. Additionally, multivariate logistic regression analysis showed that higher scores were significantly correlated with euploidy (p < 0.001). The Area Under the Curve (AUC) of iDAScore alone for predicting euploidy embryo is 0.612, but rose to 0.688 by adding clinical and embryonic characteristics. Conclusions: This study provided additional information to strengthen the clinical applicability of iDAScore. This may provide a non-invasive and inexpensive alternative for patients who have no available blastocyst for biopsy or who are economically disadvantaged. However, the accuracy of embryo ploidy is still dependent on the results of next-generation sequencing technology (NGS) analysis.


  • Open Access

    A novel non-invasive embryo evaluation method (NICS-Timelapse) with enhanced predictive precision and clinical impact

    by Hui He, Li Wu, Yulin Chen, Tuan Li, Xinling Ren, Juan Hu, Jinming Liu, Wen Chen, Bingxin Ma, Yangyun Zou, et al.


  • Application of artificial intelligence in gametes and embryos selection

    by Keyi Si, Bo Huang, Lei Jin

    Gamete and embryo quality are critical to the success rate of Assisted Reproductive Technology (ART) cycles, but there remains a lack of methods to accurately measure the quality of sperm, oocytes and embryos. The ability of Artificial Intelligence (AI) technology to analyze large amounts of data, especially video and images, is particularly useful in gamete and embryo assessment and selection. The well-trained model has fast calculation speed and high accuracy, which can help embryologists to perform more objective gamete and embryo selection. Various artificial intelligence models have been developed for gamete and embryo assessment, some of which exhibit good performance. In this review, we summarize the latest applications of AI technology in semen analysis, as well as selection for sperm, oocyte and embryo, and discuss the existing problems and development directions of artificial intelligence in this field.